Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study
Authors not listed
University of Colorado, Denver · 2016
Abstract
This study plans to establish a large bank of blood, cerebral spinal fluid (CSF), imaging, and clinical data. These data and samples will be used for future research into the causes of Alzheimer's disease (AD), Down Syndrome (DS) and other diseases that cause thinking and memory problems. This future research will also study how treatments for these diseases work. This research may help develop new treatments for some diseases of the nervous system and help understand these diseases better.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2016). Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study. <em>University of Colorado, Denver</em>. https://clinicaltrials.gov/study/NCT02612376
Vancouver
Anonymous. Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study. University of Colorado, Denver. 2016.
BibTeX
@misc{anon2016RockyM,
title = {Rocky Mountain Alzheimer's Disease Center at the University of Colorado School of Medicine (RMADC at UCSOM) Longitudinal Biomarker and Clinical Phenotyping Study},
author = {Anonymous},
journal = {University of Colorado, Denver},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Colorado, Denver 2019
Open access · US-GOV
Investigating the Contribution of Peripheral Versus Central Nervous System Dysfunction to Cognitive Aging
University of Cambridge 2025
Open access · US-GOV
Met-Pro Study: The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
Beijing Friendship Hospital 2015
Open access · US-GOV
Monetary Cost of Alzheimer's Disease in China: Study Protocol for a Cluster Randomized Observational Study
Ontario Neurodegeneration Disease Research Initiative 2021
Open access · US-GOV
Health in Aging, Neurodegenerative Diseases and Dementias In Ontario
National Eye Institute (NEI) 2006
Open access · US-GOV
National Ophthalmic Genotyping and Phenotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
University of Edinburgh 2019
Open access · US-GOV